BRF
ARNA

B. Riley Financial’s Arena Pharmaceuticals Inc ARNA Stock Holding History

B. Riley Financial’s Portfolio ARNA Stock Details ARNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-8,010
Closed -$204K – 356
2017
Q3 		$204K Buy
+8,010
New +$184K 0.06% 269

Other funds holding ARNA

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

B. Riley Financial's ARNA Position: Q4 2017 in Review

B. Riley Financial sold out of Arena Pharmaceuticals Inc (ARNA) in Q4 2017, closing a stake of 8,010 shares — an estimated $204K sold.

B. Riley Financial first reported a position in ARNA in Q3 2017 and held it in 1 quarter. The position peaked at $204K in Q3 2017. 125 funds tracked by Wall St. Rank hold ARNA as of Q4 2017.

  • B. Riley Financial reported no remaining Arena Pharmaceuticals Inc position as of Q4 2017 after selling out during the quarter.
  • B. Riley Financial sold 8,010 Arena Pharmaceuticals Inc shares in Q4 2017, an estimated $204K.
  • B. Riley Financial first reported a position in Arena Pharmaceuticals Inc in Q3 2017 and held it in 1 quarter.
  • B. Riley Financial's Arena Pharmaceuticals Inc position peaked at $204K in Q3 2017.
  • 125 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q4 2017.

Based on B. Riley Financial's 13F filing for Q4 2017, filed 9 Feb 2018.